SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Dean C. Ripple, Christopher B. Montgomery, Zhishang Hu, An Interlaboratory Comparison of Sizing and Counting of Subvisible Particles Mimicking Protein Aggregates, Journal of Pharmaceutical Sciences, 2015, 104, 2
  2. 2
    Satish K. Singh, Donna L. Luisi, Roger H. Pak, Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability, Pharmaceutical Research, 2015, 32, 11, 3541

    CrossRef

  3. 3
    Zahra Hamrang, Maryam Hussain, Katie Tingey, Malgorzata Tracka, José R. Casas-Finet, Shahid Uddin, Christopher F. van der Walle, Alain Pluen, Characterisation of Stress-Induced Aggregate Size Distributions and Morphological Changes of a Bi-Specific Antibody Using Orthogonal Techniques, Journal of Pharmaceutical Sciences, 2015, 104, 8
  4. 4
    Chen Zhou, Aaron B. Krueger, James G. Barnard, Wei Qi, John F. Carpenter, Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins, Journal of Pharmaceutical Sciences, 2015, 104, 8
  5. 5
    Rekha Vasudev, Sam Mathew, Nataliya Afonina, Characterization of Submicron (0.1–1 μm) Particles in Therapeutic Proteins by Nanoparticle Tracking Analysis, Journal of Pharmaceutical Sciences, 2015, 104, 5
  6. 6
    Chen Zhou, Wei Qi, E. Neil Lewis, John F. Carpenter, Concomitant Raman spectroscopy and dynamic light scattering for characterization of therapeutic proteins at high concentrations, Analytical Biochemistry, 2015, 472, 7

    CrossRef

  7. 7
    Dean C. Ripple, Zhishang Hu, Correcting the Relative Bias of Light Obscuration and Flow Imaging Particle Counters, Pharmaceutical Research, 2015,

    CrossRef

  8. 8
    Emilien Folzer, Tarik A. Khan, Roland Schmidt, Christof Finkler, Jörg Huwyler, Hanns-Christian Mahler, Atanas V. Koulov, Determination of the Density of Protein Particles Using a Suspended Microchannel Resonator, Journal of Pharmaceutical Sciences, 2015, 104, 12
  9. 9
    Alana Gerhardt, Bao H. Nguyen, Rachael Lewus, John F. Carpenter, Theodore W. Randolph, Effect of the Siliconization Method on Particle Generation in a Monoclonal Antibody Formulation in Pre-filled Syringes, Journal of Pharmaceutical Sciences, 2015, 104, 5
  10. 10
    Anacelia Ríos Quiroz, Jens Lamerz, Thierry Da Cunha, Adeline Boillon, Michael Adler, Christof Finkler, Joerg Huwyler, Roland Schmidt, Hanns-Christian Mahler, Atanas V. Koulov, Factors Governing the Precision of Subvisible Particle Measurement Methods – A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe, Pharmaceutical Research, 2015,

    CrossRef

  11. You have free access to this content11
    Christine C. Siska, Christopher J. Pierini, Hollis R. Lau, Ramil F. Latypov, R. Matthew Fesinmeyer, Jennifer R. Litowski, Free Fatty Acid Particles in Protein Formulations, Part 2: Contribution of Polysorbate Raw Material, Journal of Pharmaceutical Sciences, 2015, 104, 2
  12. 12
    Miguel Saggu, Jun Liu, Ankit Patel, Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway, Pharmaceutical Research, 2015, 32, 9, 2877

    CrossRef

  13. 13
    Valérie Carnovale, Michel Britten, Charles Couillard, Laurent Bazinet, Impact of calcium on the interactions between epigallocatechin-3-gallate and β-lactoglobulin, Food Research International, 2015, 77, 565

    CrossRef

  14. 14
    Tim Menzen, Wolfgang Friess, Reinhard Niessner, Christoph Haisch, Laser-induced breakdown detection of temperature-ramp generated aggregates of therapeutic monoclonal antibody, European Journal of Pharmaceutics and Biopharmaceutics, 2015, 94, 463

    CrossRef

  15. 15
    Benjamin Patrick Werner, Gerhard Winter, Particle contamination of parenteralia and in-line filtration of proteinaceous drugs, International Journal of Pharmaceutics, 2015, 496, 2, 250

    CrossRef

  16. 16
    Verena Saller, Julia Matilainen, Ulla Grauschopf, Karoline Bechtold-Peters, Hanns-Christian Mahler, Wolfgang Friess, Particle Shedding from Peristaltic Pump Tubing in Biopharmaceutical Drug Product Manufacturing, Journal of Pharmaceutical Sciences, 2015, 104, 4
  17. 17
    Eoin G. Murphy, Yrjö H. Roos, Sean A. Hogan, Patrick G. Maher, Cal G. Flynn, Mark A. Fenelon, Physical stability of infant milk formula made with selectively hydrolysed whey proteins, International Dairy Journal, 2015, 40, 39

    CrossRef

  18. 18
    Carmen R. M. Bria, Jeffery Jones, Alexander Charlesworth, Siriwan Kim Ratanathanawongs Williams, Probing Submicron Aggregation Kinetics of an IgG Protein by Asymmetrical Flow Field-Flow Fractionation, Journal of Pharmaceutical Sciences, 2015, 104, 12
  19. 19
    Ahmad S. Sediq, M. Reza Nejadnik, Inas El Bialy, Geert-Jan Witkamp, Wim Jiskoot, Protein–polyelectrolyte interactions: Monitoring particle formation and growth by nanoparticle tracking analysis and flow imaging microscopy, European Journal of Pharmaceutics and Biopharmaceutics, 2015, 93, 339

    CrossRef

  20. 20
    Anne R. Karow, Jana Götzl, Patrick Garidel, Resolving power of dynamic light scattering for protein and polystyrene nanoparticles, Pharmaceutical Development and Technology, 2015, 20, 1, 84

    CrossRef

  21. 21
    Linda O. Narhi, Vincent Corvari, Dean C. Ripple, Nataliya Afonina, Irene Cecchini, Michael R. Defelippis, Patrick Garidel, Andrea Herre, Atanas V. Koulov, Tony Lubiniecki, Hanns-Christian Mahler, Paolo Mangiagalli, Douglas Nesta, Bernardo Perez-Ramirez, Alla Polozova, Mara Rossi, Roland Schmidt, Robert Simler, Satish Singh, Thomas M. Spitznagel, Andrew Weiskopf, Klaus Wuchner, Subvisible (2–100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy, Journal of Pharmaceutical Sciences, 2015, 104, 6
  22. 22
    Vincent Corvari, Linda O. Narhi, Thomas M. Spitznagel, Nataliya Afonina, Shawn Cao, Patricia Cash, Irene Cecchini, Michael R. DeFelippis, Patrick Garidel, Andrea Herre, Atanas V. Koulov, Tony Lubiniecki, Hanns-Christian Mahler, Paolo Mangiagalli, Douglas Nesta, Bernardo Perez-Ramirez, Alla Polozova, Mara Rossi, Roland Schmidt, Robert Simler, Satish Singh, Andrew Weiskopf, Klaus Wuchner, Subvisible (2–100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis, Biologicals, 2015, 43, 6, 457

    CrossRef

  23. 23
    Biosimilars and Interchangeable Biologics, 2015,

    CrossRef

  24. 24
    Therapeutic Peptides and Proteins, 2015,

    CrossRef

  25. 25
    Therapeutic Peptides and Proteins, 2015,

    CrossRef

  26. 26
    Andrea Hawe, Sarah Zölls, Angelika Freitag, John F. Carpenter, Biophysical Characterization of Proteins in Developing Biopharmaceuticals, 2015,

    CrossRef

  27. 27
    Dean C. Ripple, Linda O. Narhi, State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study, 2015,

    CrossRef

  28. 28
    Gayathri Ratnaswamy, Alison Hair, Gary Li, Renuka Thirumangalathu, Yasser Nashed-Samuel, Lejla Brych, Vasumathi Dharmavaram, Zai-Qing Wen, Kiyoshi Fujimori, Wendy Jing, Ananth Sethuraman, Rob Swift, Margaret Speed Ricci, Deirdre Murphy Piedmonte, A Case Study of Nondelamination Glass Dissolution Resulting in Visible Particles: Implications for Neutral pH Formulations, Journal of Pharmaceutical Sciences, 2014, 103, 4
  29. 29
    J. Ray Runyon, Matilda Ulmius, Lars Nilsson, A perspective on the characterization of colloids and macromolecules using asymmetrical flow field-flow fractionation, Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2014, 442, 25

    CrossRef

  30. 30
    Constanze Lamprecht, Peter Hinterdorfer, Andreas Ebner, Applications of biosensing atomic force microscopy in monitoring drug and nanoparticle delivery, Expert Opinion on Drug Delivery, 2014, 11, 8, 1237

    CrossRef

  31. 31
    Tobias Werk, David B. Volkin, Hanns-Christian Mahler, Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods, European Journal of Pharmaceutical Sciences, 2014, 53, 95

    CrossRef

  32. 32
    Dennis T. Yang, Xiaomeng Lu, Yamin Fan, Regina M. Murphy, Evaluation of nanoparticle tracking for characterization of fibrillar protein aggregates, AIChE Journal, 2014, 60, 4
  33. 33
    Peter Lassner, Michael Adler, Geoffrey Lee, Formation of Insoluble Particulates in a Spray-Dried F(ab’)2 Fragment, Journal of Pharmaceutical Sciences, 2014, 103, 4
  34. 34
    Rajoshi Chaudhuri, Yuan Cheng, C. Russell Middaugh, David B. Volkin, High-Throughput Biophysical Analysis of Protein Therapeutics to Examine Interrelationships Between Aggregate Formation and Conformational Stability, The AAPS Journal, 2014, 16, 1, 48

    CrossRef

  35. 35
    V. Marassi, B. Roda, A. Zattoni, M. Tanase, P. Reschiglian, Hollow fiber flow field-flow fractionation and size-exclusion chromatography with multi-angle light scattering detection: A complementary approach in biopharmaceutical industry, Journal of Chromatography A, 2014, 1372, 196

    CrossRef

  36. 36
    P. Reschiglian, B. Roda, A. Zattoni, M. Tanase, V. Marassi, S. Serani, Hollow-fiber flow field-flow fractionation with multi-angle laser scattering detection for aggregation studies of therapeutic proteins, Analytical and Bioanalytical Chemistry, 2014, 406, 6, 1619

    CrossRef

  37. 37
    Kirsty D. Ratanji, Jeremy P. Derrick, Rebecca J. Dearman, Ian Kimber, Immunogenicity of therapeutic proteins: Influence of aggregation, Journal of Immunotoxicology, 2014, 11, 2, 99

    CrossRef

  38. 38
    Hirotaka Nishi, Roman Mathäs, Robert Fürst, Gerhard Winter, Label-Free Flow Cytometry Analysis of Subvisible Aggregates in Liquid IgG1 Antibody Formulations, Journal of Pharmaceutical Sciences, 2014, 103, 1
  39. 39
    Subhashchandra Naik, Ozan S. Kumru, Melissa Cullom, Srivalli N. Telikepalli, Elizabeth Lindboe, Taylor L. Roop, Sangeeta B. Joshi, Divya Amin, Phillip Gao, C. Russell Middaugh, David B. Volkin, Mark T. Fisher, Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometry, Protein Science, 2014, 23, 10
  40. 40
    Alana Gerhardt, Nicole R. Mcgraw, Daniel K. Schwartz, Jared S. Bee, John F. Carpenter, Theodore W. Randolph, Protein Aggregation and Particle Formation in Prefilled Glass Syringes, Journal of Pharmaceutical Sciences, 2014, 103, 6
  41. 41
    Samiul Amin, Gregory V. Barnett, Jai A. Pathak, Christopher J. Roberts, Prasad S. Sarangapani, Protein aggregation, particle formation, characterization & rheology, Current Opinion in Colloid & Interface Science, 2014, 19, 5, 438

    CrossRef

  42. 42
    Srivalli N. Telikepalli, Ozan S. Kumru, Cavan Kalonia, Reza Esfandiary, Sangeeta B. Joshi, C. Russell Middaugh, David B. Volkin, Structural Characterization of IgG1 mAb Aggregates and Particles Generated Under Various Stress Conditions, Journal of Pharmaceutical Sciences, 2014, 103, 3
  43. 43
    Tim Menzen, Wolfgang Friess, Temperature-Ramped Studies on the Aggregation, Unfolding, and Interaction of a Therapeutic Monoclonal Antibody, Journal of Pharmaceutical Sciences, 2014, 103, 2
  44. 44
    Mingsheng Xu, Daisuke Fujita, Huanxing Su, Hongzheng Chen, Nobutaka Hanagata, Biointeractions of Nanomaterials, 2014,

    CrossRef

  45. 45
    Vasco Filipe, Andrea Hawe, John F. Carpenter, Wim Jiskoot, Analytical approaches to assess the degradation of therapeutic proteins, TrAC Trends in Analytical Chemistry, 2013, 49, 118

    CrossRef

  46. 46
    Marcia Federici, Anthony Lubiniecki, Prakash Manikwar, David B. Volkin, Analytical lessons learned from selected therapeutic protein drug comparability studies, Biologicals, 2013, 41, 3, 131

    CrossRef

  47. 47
    Aaron P. Yamniuk, Noah Ditto, Mehul Patel, Jun Dai, Preeti Sejwal, Paul Stetsko, Michael L. Doyle, Application of a kosmotrope-based solubility assay to multiple protein therapeutic classes indicates broad use as a high-throughput screen for protein therapeutic aggregation propensity, Journal of Pharmaceutical Sciences, 2013, 102, 8
  48. 48
    Roman Mathaes, Gerhard Winter, Julia Engert, Ahmed Besheer, Application of different analytical methods for the characterization of non-spherical micro- and nanoparticles, International Journal of Pharmaceutics, 2013, 453, 2, 620

    CrossRef

  49. 49
    Shujun Bai, Yogapriya Murugesan, Milana Vlasic, Lori B. Karpes, Mark L. Brader, Effects of submicron particles on formation of micron-sized particles during long-term storage of an interferon-beta-1a solution, Journal of Pharmaceutical Sciences, 2013, 102, 2
  50. 50
    Sarah Zölls, Daniel Weinbuch, Michael Wiggenhorn, Gerhard Winter, Wolfgang Friess, Wim Jiskoot, Andrea Hawe, Flow Imaging Microscopy for Protein Particle Analysis—A Comparative Evaluation of Four Different Analytical Instruments, The AAPS Journal, 2013, 15, 4, 1200

    CrossRef

  51. 51
    Sarah Zölls, Manuel Gregoritza, Ruedeeporn Tantipolphan, Michael Wiggenhorn, Gerhard Winter, Wolfgang Friess, Andrea Hawe, How subvisible particles become invisible—relevance of the refractive index for protein particle analysis, Journal of Pharmaceutical Sciences, 2013, 102, 5
  52. 52
    Daniel Weinbuch, Sarah Zölls, Michael Wiggenhorn, Wolfgang Friess, Gerhard Winter, Wim Jiskoot, Andrea Hawe, Micro–flow imaging and resonant mass measurement (archimedes) – complementary methods to quantitatively differentiate protein particles and silicone oil droplets, Journal of Pharmaceutical Sciences, 2013, 102, 7
  53. 53
    Zahra Hamrang, Nicholas J.W. Rattray, Alain Pluen, Proteins behaving badly: emerging technologies in profiling biopharmaceutical aggregation, Trends in Biotechnology, 2013, 31, 8, 448

    CrossRef

  54. 54
    Cavan Kalonia, Ozan S. Kumru, Jae Hyun Kim, C. Russell Middaugh, David B. Volkin, Radar Chart Array Analysis to Visualize Effects of Formulation Variables on IgG1 Particle Formation as Measured by Multiple Analytical Techniques, Journal of Pharmaceutical Sciences, 2013, 102, 12
  55. 55
    Janice M. Davis, Ning Zhang, Robert W. Payne, Brian M. Murphy, Ahmad M. Abdul-Fattah, James E. Matsuura, Alan C. Herman, Mark Cornell Manning, Stability of lyophilized sucrose formulations of an IgG1: subvisible particle formation, Pharmaceutical Development and Technology, 2013, 18, 4, 883

    CrossRef

  56. 56
    Andrea Hawe, Stefan Romeijn, Vasco Filipe, Wim Jiskoot, Asymmetrical flow field-flow fractionation method for the analysis of submicron protein aggregates, Journal of Pharmaceutical Sciences, 2012, 101, 11
  57. 57
    Ozan S. Kumru, Jun Liu, Junyan A. Ji, Wilson Cheng, Y. John Wang, Tingting Wang, Sangeeta B. Joshi, C. Russell Middaugh, David B. Volkin, Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags, Journal of Pharmaceutical Sciences, 2012, 101, 10
  58. 58
    Chakravarthy Narasimhan, Henryk Mach, Mohammed Shameem, High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspective, Therapeutic Delivery, 2012, 3, 7, 889

    CrossRef

  59. 59
    Wei Wang, Satish K. Singh, Ning Li, Maria R. Toler, Kevin R. King, Sandeep Nema, Immunogenicity of protein aggregates—Concerns and realities, International Journal of Pharmaceutics, 2012, 431, 1-2, 1

    CrossRef

  60. 60
    Miranda M. C. van Beers, Muriel Bardor, Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins, Biotechnology Journal, 2012, 7, 12
  61. 61
    Jared S. Bee, Daniel K. Schwartz, Siwar Trabelsi, Erwin Freund, Jennifer L. Stevenson, John F. Carpenter, Theodore W. Randolph, Production of particles of therapeutic proteins at the air–water interface during compression/dilation cycles, Soft Matter, 2012, 8, 40, 10329

    CrossRef

  62. 62
    Dean C. Ripple, Mariana N. Dimitrova, Protein particles: What we know and what we do not know, Journal of Pharmaceutical Sciences, 2012, 101, 10
  63. 63
    Flora Felsovalyi, Sébastien Janvier, Sébastien Jouffray, Hervé Soukiassian, Paolo Mangiagalli, Silicone-oil-based subvisible particles: Their detection, interactions, and regulation in prefilled container closure systems for biopharmaceuticals, Journal of Pharmaceutical Sciences, 2012, 101, 12
  64. 64
    Jared S. Bee, Theresa J. Goletz, Jack A. Ragheb, The future of protein particle characterization and understanding its potential to diminish the immunogenicity of biopharmaceuticals: A shared perspective, Journal of Pharmaceutical Sciences, 2012, 101, 10
  65. 65
    Lucette Doessegger, Hanns-Christian Mahler, Piotr Szczesny, Helmut Rockstroh, Georg Kallmeyer, Anja Langenkamp, Joerg Herrmann, Joseph Famulare, The potential clinical relevance of visible particles in parenteral drugs, Journal of Pharmaceutical Sciences, 2012, 101, 8
  66. 66
    Zahra Shahrokh, Nazila Salamat-Miller, John J. Thomas, Biophysical Analyses Suitable for Chemistry, Manufacturing, and Control Sections of the Biologic License Application (BLA),
  67. 67
    Thomas P. Burg, Devices with Embedded Channels,